Home
Conditions
Meningococcal Infections

Clinical trial condition

Meningococcal Infections

Explore clinical trials studying Meningococcal Infections. Study availability and eligibility vary by location and protocol.

216 public trials 4 recruiting studies

Refine in advanced search Browse all conditions

Meningococcal Infections trial results

Completed

Safety of Purified Meningococcal Vaccine With Serogroups ACWY, in 3,000 Filipino Subjects Aged > 2 Years

NCT00290329

Conditions: Bacterial Infections, Bacterial Infections and Mycoses, Gram-Negative Bacterial Infections, +4 more
Locations: GSK Investigational Site Alabang, Muntinlupa City, Philippines

GSK Investigational Site Binangonan, Rizal, Philippines

GSK Investigational Site Cainta, Rizal, Philippines

GSK Investigational Site City of Muntinlupa, Philippines

View Trial Details

Completed

Safety & Immunogenicity of 1 Dose of GSK134612 in Children 12-14 Months and 3-5 Years Old

NCT00196976

Conditions: Bacterial Infections, Bacterial Infections and Mycoses, Gram-Negative Bacterial Infections, +4 more
Locations: GSK Investigational Site Eferding, Austria

GSK Investigational Site Graz, Austria

GSK Investigational Site Salzburg, Austria

GSK Investigational Site Vienna, Austria

View all 17 locations

View Trial Details

Completed

Study to Asses DTPw-HBV/Hib at 15-18 Months (m) and Mencevax™ ACW at 24 to 30 m in Primed Subjects

NCT00317109

Conditions: Bacterial Infections, Bacterial Infections and Mycoses, Blood-Borne Infections, +23 more
Locations: GSK Investigational Site Brits, South Africa

GSK Investigational Site Ga-Rankuwa, South Africa

GSK Investigational Site Rooihuiskraal, South Africa

View Trial Details

Completed

Immune Response & Safety of GSK Biologicals' Mencevax™ ACWY in Subjects Primed in the DTPW-HBV=HIB-MENAC-TT-011 Study

NCT00291343

Conditions: Bacterial Infections, Bacterial Infections and Mycoses, Blood-Borne Infections, +23 more
Locations: GSK Investigational Site Manila, Philippines

GSK Investigational Site Sampaloc, Manila, Philippines

View Trial Details

Completed

Study in Children to Evaluate Non-Inferiority and Persistence up to 5 Years of GSK Bio Meningococcal Vaccine 134612

NCT00427908

Conditions: Bacterial Infections, Bacterial Infections and Mycoses, Gram-Negative Bacterial Infections, +4 more
Locations: GSK Investigational Site Espoo, Finland

GSK Investigational Site Helsinki, Finland

GSK Investigational Site Helsinki, Finland

GSK Investigational Site Jarvenpaa, Finland

View Trial Details

Completed

Co-administration of Meningococcal Vaccine GSK134612 and Pneumococcal Vaccine GSK1024850A vs Individual Administration

NCT00758264

Conditions: Bacterial Infections, Bacterial Infections and Mycoses, Gram-Negative Bacterial Infections, +4 more
Locations: GSK Investigational Site Mexico City, Mexico

GSK Investigational Site México, Mexico

GSK Investigational Site Taipei, Taiwan

GSK Investigational Site Taipei, Taiwan

View Trial Details

Completed

N. Meningitidis Carriage Study

NCT01808365

Conditions: Bacterial Infections, Bacterial Infections and Mycoses, Gram-Negative Bacterial Infections, +4 more
Locations: GSK Investigational Site Manila, Philippines

View Trial Details

Completed

Safety and Immunogenicity of a Quadrivalent Meningococcal Tetanus Protein Conjugate Vaccine in Toddlers

NCT00631995

Conditions: Bacterial Infections, Bacterial Infections and Mycoses, Gram-Negative Bacterial Infections, +7 more
Locations: Herston, Australia

Melbourne, Australia

North Adelaide, Australia

Perth, Australia

View Trial Details

Completed

Safety of a Meningococcal (Groups A, C, Y and W-135) Polysaccharide Diphtheria Toxoid Conjugate Vaccine in Healthy Subjects in Vietnam

NCT02640404

Conditions: Bacterial Infections, Bacterial Infections and Mycoses, Central Nervous System Bacterial Infections, +12 more
Locations: Vĩnh Long, Vinh Long Province, Vietnam

View Trial Details

Completed

Phase 1 Safety and Immunogenicity of Meningococcal Vaccine

NCT00678652

Conditions: Bacterial Infections, Bacterial Infections and Mycoses, Gram-Negative Bacterial Infections, +4 more
Locations: Clinical Trials Center, WRAIR Silver Spring, Maryland, United States

View Trial Details

Meningococcal Infections

Meningococcal Infections trial results

Related conditions